title: Coverage of Prandial Insulin Requirements: An Elusive Goal.
authors.affiliation: 1 Science & Co. , Düsseldorf, Germany .
authors.forename: Lutz
authors.initials: L
authors.lastname: Heinemann
authors.affiliation: 2 Kinexum , San Diego, California.
authors.forename: Douglas
authors.initials: D
authors.lastname: Muchmore
mesh_terms: D003131:Combined Modality Therapy / Q000009:adverse effects; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000628:therapy; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control*; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D062407:Meals; D019518:Postprandial Period; D057285:Precision Medicine
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin